BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20491633)

  • 1. A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling.
    Labar G; Wouters J; Lambert DM
    Curr Med Chem; 2010; 17(24):2588-607. PubMed ID: 20491633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors.
    Savinainen JR; Saario SM; Laitinen JT
    Acta Physiol (Oxf); 2012 Feb; 204(2):267-76. PubMed ID: 21418147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid overload.
    Lichtman AH; Blankman JL; Cravatt BF
    Mol Pharmacol; 2010 Dec; 78(6):993-5. PubMed ID: 20952498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala.
    Serrano A; Rivera P; Pavon FJ; Decara J; Suárez J; Rodriguez de Fonseca F; Parsons LH
    Alcohol Clin Exp Res; 2012 Jun; 36(6):984-94. PubMed ID: 22141465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of the endocannabinoid-degrading enzymes, or how to increase endocannabinoid's activity by preventing their hydrolysis.
    Feledziak M; Lambert DM; Marchand-Brynaert J; Muccioli GG
    Recent Pat CNS Drug Discov; 2012 Apr; 7(1):49-70. PubMed ID: 22280341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The medicinal chemistry of agents targeting monoacylglycerol lipase.
    Viso A; Cisneros JA; Ortega-Gutiérrez S
    Curr Top Med Chem; 2008; 8(3):231-46. PubMed ID: 18289090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling.
    Labar G; Bauvois C; Borel F; Ferrer JL; Wouters J; Lambert DM
    Chembiochem; 2010 Jan; 11(2):218-27. PubMed ID: 19957260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation.
    Alvarez-Jaimes LJ; Palmer JA
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1644-59. PubMed ID: 21466449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoacylglycerol lipase (MAGL) as a promising therapeutic target.
    Gil-Ordóñez A; Martín-Fontecha M; Ortega-Gutiérrez S; López-Rodríguez ML
    Biochem Pharmacol; 2018 Nov; 157():18-32. PubMed ID: 30059673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice.
    Pan B; Wang W; Zhong P; Blankman JL; Cravatt BF; Liu QS
    J Neurosci; 2011 Sep; 31(38):13420-30. PubMed ID: 21940435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocannabinoid system in neurodegeneration.
    Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
    Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.
    Ueda N; Tsuboi K; Uyama T; Ohnishi T
    Biofactors; 2011; 37(1):1-7. PubMed ID: 21328621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum.
    Chen Y; Liu X; Vickstrom CR; Liu MJ; Zhao L; Viader A; Cravatt BF; Liu QS
    eNeuro; 2016; 3(3):. PubMed ID: 27182552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
    Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
    Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling.
    Labar G; Bauvois C; Muccioli GG; Wouters J; Lambert DM
    Chembiochem; 2007 Jul; 8(11):1293-7. PubMed ID: 17579916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation.
    Gomez O; Arevalo-Martin A; Garcia-Ovejero D; Ortega-Gutierrez S; Cisneros JA; Almazan G; Sánchez-Rodriguez MA; Molina-Holgado F; Molina-Holgado E
    Glia; 2010 Dec; 58(16):1913-27. PubMed ID: 20878765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids.
    Kohnz RA; Nomura DK
    Chem Soc Rev; 2014 Oct; 43(19):6859-69. PubMed ID: 24676249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer.
    Nomura DK; Lombardi DP; Chang JW; Niessen S; Ward AM; Long JZ; Hoover HH; Cravatt BF
    Chem Biol; 2011 Jul; 18(7):846-56. PubMed ID: 21802006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.